Special molecules called fluorophores could ‘light up’ living cancer cells in future treatment of neuroblastoma, with new research by our GOSH doctors underway.
Researchers and doctors at GOSH have long been at the forefront of developing new treatments for Spinal Muscular Atrophy (SMA) and new research this year is helping us understand how Zolgensma, a gene therapy, can help.
Researchers at GOSH and UCL are the first to identify 'pre-resistance' signs in bacteria, indicators that particular bacteria are likely to become resistant to antibiotics in the future. This will allow doctors in the future to select the best treatments
For the first time, an international team of scientists and doctors have used these advances to develop a lab-grown model of the human stomach. This can be used to study how infections in humans impact the gastrointestinal system.
Unborn babies are mostly protected from COVID-19 by the placenta, but may become infected if their gut is exposed to the SARS-CoV-2 virus, reveals a new study from GOSH and UCL GOS ICH.